Peng Hui Chen

Peng Hui Chen is the founder of NuProbe USA, Inc. Current positions include Independent Non-Executive Director at Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since 2025, Independent Non-Executive Director at VCREDIT Holdings Ltd. since 2018, and Director at Qianglian Zhichuang (Beijing) Technology Co., Ltd. Former roles include Managing Director at China Everbright Holdings Co. Ltd. from 2011 to 2014, Director at Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. from 2015 to 2017, President, COO, CFO, Director & CAO at Shangpharma Corp.
from 2010 to 2011, Director at BGI Genomics Co., Ltd., Independent Non-Executive Director at Hygeia Healthcare Holdings Co., Ltd. from 2019 to 2022, Independent Director at Bright Eye Hospital Group Co., Ltd. from 2019 to 2025, Non-Executive Director at CF PharmTech, Inc from 2020 to 2026, Manager-Business Development at EIDP, Inc. in 2006, Principal at Ligand Pharmaceuticals, Inc., Vice President at CITIC Capital Holdings Ltd., and Partner at Wuhan HongShan Huanxia Technology Co., Ltd. Education includes a graduate degree from Tulane University (Louisiana) in 1998, an undergraduate degree from Nanjing University in 1993, and an MBA from Kellogg School of Management in 2003.